L.A.B. Joosten

543 total citations
19 papers, 430 citations indexed

About

L.A.B. Joosten is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, L.A.B. Joosten has authored 19 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in L.A.B. Joosten's work include Rheumatoid Arthritis Research and Therapies (6 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Inflammasome and immune disorders (3 papers). L.A.B. Joosten is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Inflammasome and immune disorders (3 papers). L.A.B. Joosten collaborates with scholars based in Netherlands, United States and Italy. L.A.B. Joosten's co-authors include Wim B. van den Berg, Marije I. Koenders, Fons A. J. van de Loo, Erik Lubberts, Paul Schwarzenberger, Onno J. Arntz, Pernette J. Verschure, P.M. van der Kraan, Jan van Marle and Joost Schalkwijk and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinical Pharmacology & Therapeutics and Atherosclerosis.

In The Last Decade

L.A.B. Joosten

19 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.A.B. Joosten Netherlands 9 190 180 105 87 55 19 430
Sonja Herman Austria 9 176 0.9× 163 0.9× 240 2.3× 112 1.3× 31 0.6× 12 595
Diana C. Brinson United States 10 261 1.4× 102 0.6× 226 2.2× 82 0.9× 82 1.5× 11 575
Joerg H W Distler Germany 5 121 0.6× 68 0.4× 149 1.4× 69 0.8× 25 0.5× 8 340
Akilan Krishnamurthy Sweden 10 300 1.6× 229 1.3× 199 1.9× 106 1.2× 25 0.5× 25 664
Jin-Ah Baek South Korea 9 80 0.4× 147 0.8× 94 0.9× 54 0.6× 26 0.5× 14 325
S Miyamoto Japan 10 124 0.7× 77 0.4× 129 1.2× 71 0.8× 27 0.5× 18 461
Stefan N. Andersen Netherlands 8 279 1.5× 90 0.5× 85 0.8× 51 0.6× 76 1.4× 10 421
Iwona Janicka Poland 9 88 0.5× 122 0.7× 117 1.1× 38 0.4× 16 0.3× 18 357
Weihong Yin United States 12 146 0.8× 67 0.4× 254 2.4× 98 1.1× 42 0.8× 15 498
Hiroomi Tateishi Japan 9 155 0.8× 72 0.4× 89 0.8× 49 0.6× 40 0.7× 14 330

Countries citing papers authored by L.A.B. Joosten

Since Specialization
Citations

This map shows the geographic impact of L.A.B. Joosten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.A.B. Joosten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.A.B. Joosten more than expected).

Fields of papers citing papers by L.A.B. Joosten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.A.B. Joosten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.A.B. Joosten. The network helps show where L.A.B. Joosten may publish in the future.

Co-authorship network of co-authors of L.A.B. Joosten

This figure shows the co-authorship network connecting the top 25 collaborators of L.A.B. Joosten. A scholar is included among the top collaborators of L.A.B. Joosten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.A.B. Joosten. L.A.B. Joosten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rösler, Berenice, Bas Heinhuis, Ricardo Silvestre, et al.. (2020). Mimicking Behçet's disease: GM-CSF gain of function mutation in a family suffering from a Behçet's disease-like disorder marked by extreme pathergy. Clinical & Experimental Immunology. 204(2). 189–198. 4 indexed citations
2.
Munckhof, Inge van den, Rob ter Horst, Kiki Schraa, et al.. (2019). Il-18 Binding Protein: A Novel Biomarker In Obesity-Related Atherosclerosis That Modulates Lipoprotein Metabolism. Atherosclerosis. 287. e75–e75. 3 indexed citations
3.
Klück, Viola, M. Janssen, Tim Jansen, et al.. (2019). P159/O30 OLT1177™, an oral NLRP3 inflammasome inhibitor, inhibits acute joint inflammation and circulating IL 1β during gout flares in humans. Annals of the Rheumatic Diseases. 78. A69–A69. 3 indexed citations
4.
Tweehuysen, Lieke, Alfons A den Broeder, Kiki Schraa, et al.. (2019). Predictive value of ex-vivo drug-inhibited cytokine production for clinical response to biologic DMARD therapy in rheumatoid arthritis.. PubMed. 37(3). 367–372. 6 indexed citations
5.
Ceglie, Irene Di, Martijn H. J. van den Bosch, Birgitte Walgreen, et al.. (2019). High LDL-C levels attenuate onset of inflammation and cartilage destruction in antigen-induced arthritis.. PubMed. 37(6). 983–993. 3 indexed citations
6.
Jansen, Tim, Viola Klück, M. Janssen, et al.. (2019). P160 The first phase 2A proof-of-concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout. Annals of the Rheumatic Diseases. 78. A70–A71. 15 indexed citations
7.
Tweehuysen, Lieke, Kiki Schraa, Mihai G. Netea, et al.. (2018). Ex vivo inhibited cytokine profiling may explain inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis.. PubMed. 36(1). 140–143. 1 indexed citations
8.
Roerink, Megan E., Marieke E. van der Schaaf, Lukas J.A.C. Hawinkels, et al.. (2018). Pitfalls in cytokine measurements - Plasma TGF-β1 in chronic fatigue syndrome.. PubMed. 76(7). 310–313. 9 indexed citations
9.
Plantinga, Theo S., Peer Arts, L.A.B. Joosten, et al.. (2017). Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease. Clinical Pharmacology & Therapeutics. 102(6). 1017–1024. 10 indexed citations
10.
Cavalli, Giulio, Dov B. Ballak, Kristen E. Boyle, et al.. (2017). OP0092 Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration and improves exercise tolerance. Annals of the Rheumatic Diseases. 76. 90–90. 1 indexed citations
11.
Marchetti, Carlo, Benjamin J. Swartzwelter, Marije I. Koenders, CA Dinarello, & L.A.B. Joosten. (2017). OP0090 The human safe NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of experimental arthritis. Annals of the Rheumatic Diseases. 76. 89–89. 5 indexed citations
12.
Koenders, Marije I., L.A.B. Joosten, & Wim B. van den Berg. (2006). Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Annals of the Rheumatic Diseases. 65. iii29–iii33. 111 indexed citations
13.
Vossenaar, E.R., et al.. (2003). Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Research. 5(Suppl 1). 30–30. 2 indexed citations
14.
Lubberts, Erik, et al.. (2002). Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflammation Research. 51(2). 102–104. 117 indexed citations
15.
Berg, Wim B. van den, L.A.B. Joosten, & Fons A. J. van de Loo. (1999). TNFa and IL-1B are separate targets in chronic arthritis. Clinical and Experimental Rheumatology. 17(6). 3 indexed citations
16.
Berg, Wim B. van den, et al.. (1999). Animal models of arthritis in NOS2-deficient mice. Osteoarthritis and Cartilage. 7(4). 413–415. 59 indexed citations
17.
Verschure, Pernette J., Jan van Marle, L.A.B. Joosten, & Wim B. van den Berg. (1995). Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis.. Annals of the Rheumatic Diseases. 54(8). 645–653. 29 indexed citations
18.
Verschure, Pernette J., L.A.B. Joosten, P.M. van der Kraan, & Wim B. van den Berg. (1994). Responsiveness of articular cartilage from normal and inflamed mouse knee joints to various growth factors.. Annals of the Rheumatic Diseases. 53(7). 455–460. 32 indexed citations
19.
Schalkwijk, Joost, L.A.B. Joosten, Wim B. van den Berg, & L. B. A. van de Putte. (1988). Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular cartilage. Inflammation Research. 23(1-2). 58–59. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonja Herman Breakdown of academic impact, for papers by Diana C. Brinson Breakdown of academic impact, for papers by Joerg H W Distler Breakdown of academic impact, for papers by Akilan Krishnamurthy Breakdown of academic impact, for papers by Jin-Ah Baek Breakdown of academic impact, for papers by S Miyamoto Breakdown of academic impact, for papers by Stefan N. Andersen Breakdown of academic impact, for papers by Iwona Janicka Breakdown of academic impact, for papers by Weihong Yin Breakdown of academic impact, for papers by Hiroomi Tateishi
Rankless by CCL
2026